Nifty
Sensex
:
:
9915.25
32028.89
41.95 (0.42%)
124.49 (0.39%)

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 506943 | NSE: JBCHEPHARM

321.60
-2.65 (-0.82%)
21-Jul-2017 | 3:51PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 323.75
  • 325.00
  • 320.05
  • 324.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 27181
  • 87.41
  • 403.90
  • 260.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,743.50
  • 15.86
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,921.97
  • 1.55%
  • 1.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.76%
  • 1.4%
  • 26.59%
  • FII
  • DII
  • Others
  • 0.06%
  • 8.08%
  • 8.11%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Standalone Figures in Rs. Crores

Description
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Jun 16
Jun 15
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
1,255.14
1,144.21
1,021.86
866.13
801.87
890.79
756.88
717.09
564.65
509.29
Net Sales Growth
9.69%
11.97%
17.98%
8.01%
-9.98%
17.69%
5.55%
27.00%
10.87%
 
Cost Of Goods Sold
374.29
341.40
413.95
371.52
320.07
277.04
178.72
187.62
141.11
121.21
Gross Profit
880.86
802.81
607.92
494.60
481.80
613.75
578.17
529.48
423.54
388.09
GP Margin
70.18%
70.16%
59.49%
57.10%
60.08%
68.90%
76.39%
73.84%
75.01%
76.20%
Total Expenditure
1,049.67
964.09
873.67
760.48
701.55
698.43
589.89
660.24
501.05
435.13
Power & Fuel Cost
55.28
53.02
46.61
39.75
29.89
23.34
18.04
15.97
16.59
13.52
% Of Sales
4.40%
4.63%
4.56%
4.59%
3.73%
2.62%
2.38%
2.23%
2.94%
2.65%
Employee Cost
184.12
159.56
143.67
130.05
112.66
124.93
91.71
87.82
85.83
77.33
% Of Sales
14.67%
13.94%
14.06%
15.02%
14.05%
14.02%
12.12%
12.25%
15.20%
15.18%
Manufacturing Exp.
243.13
223.53
102.44
61.75
52.97
60.85
102.74
108.00
77.49
77.68
% Of Sales
19.37%
19.54%
10.02%
7.13%
6.61%
6.83%
13.57%
15.06%
13.72%
15.25%
General & Admin Exp.
34.75
32.46
31.69
27.94
31.31
38.21
46.25
38.44
37.53
25.43
% Of Sales
2.77%
2.84%
3.10%
3.23%
3.90%
4.29%
6.11%
5.36%
6.65%
4.99%
Selling & Distn. Exp.
72.72
75.13
73.59
56.04
68.65
131.60
110.03
103.83
102.29
90.11
% Of Sales
5.79%
6.57%
7.20%
6.47%
8.56%
14.77%
14.54%
14.48%
18.12%
17.69%
Miscellaneous Exp.
85.38
79.01
61.72
73.44
86.00
42.47
42.41
118.56
40.20
90.11
% Of Sales
6.80%
6.91%
6.04%
8.48%
10.72%
4.77%
5.60%
16.53%
7.12%
5.86%
EBITDA
205.47
180.12
148.19
105.65
100.32
192.36
166.99
56.85
63.60
74.16
EBITDA Margin
16.37%
15.74%
14.50%
12.20%
12.51%
21.59%
22.06%
7.93%
11.26%
14.56%
Other Income
54.16
10.89
37.70
27.87
28.98
6.16
14.21
15.80
15.01
19.57
Interest
9.57
6.82
5.93
5.28
24.03
10.49
11.57
15.17
18.03
11.25
Depreciation
41.24
38.64
28.02
24.66
22.42
22.79
21.57
20.43
16.90
11.34
PBT
208.82
145.55
151.94
103.57
82.85
165.24
148.07
37.06
43.69
71.15
Tax
46.91
45.14
25.95
24.13
165.53
25.92
29.32
11.35
-1.63
8.98
Tax Rate
22.46%
31.01%
29.68%
23.30%
19.63%
15.69%
19.80%
30.63%
-3.73%
12.62%
PAT
161.88
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
62.18
PAT before Minority Interest
161.92
100.41
61.50
79.44
677.91
139.32
118.75
25.71
45.32
62.18
Minority Interest
-0.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
12.90%
8.78%
6.02%
9.17%
84.54%
15.64%
15.69%
3.59%
8.03%
12.21%
PAT Growth
61.22%
63.27%
-22.58%
-88.28%
386.58%
17.32%
361.88%
-43.27%
-27.11%
 
Unadjusted EPS
19.09
11.84
7.26
9.38
80.11
16.50
14.08
3.05
5.37
7.37

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
1,093.73
994.87
1,042.81
1,020.27
969.95
691.54
568.12
468.89
453.02
418.46
Share Capital
16.96
16.96
16.95
16.94
16.94
16.90
16.87
16.87
16.87
16.87
Total Reserves
1,076.77
977.91
1,025.82
1,003.22
952.83
674.31
550.81
451.58
435.71
401.21
Non-Current Liabilities
26.26
32.62
31.93
40.45
39.52
36.50
152.63
191.61
211.83
192.86
Secured Loans
0.00
0.00
0.09
0.22
0.40
0.54
98.49
134.30
154.50
84.20
Unsecured Loans
0.00
0.40
0.40
7.03
12.14
11.99
38.29
44.47
41.86
90.17
Long Term Provisions
10.43
12.03
12.19
8.23
8.27
7.71
0.00
0.00
0.00
0.00
Current Liabilities
435.80
459.75
276.27
239.48
188.32
271.33
116.55
85.81
76.45
100.75
Trade Payables
90.85
77.51
60.75
60.51
37.09
50.21
43.28
34.55
43.73
62.71
Other Current Liabilities
134.83
103.74
98.06
101.15
78.75
61.22
39.53
30.10
17.68
21.54
Short Term Borrowings
193.02
126.88
81.71
37.28
55.23
133.36
0.00
0.00
0.00
0.00
Short Term Provisions
17.10
151.62
35.76
40.54
17.26
26.54
33.74
21.16
15.05
16.49
Total Liabilities
1,557.39
1,487.24
1,351.01
1,300.20
1,197.79
999.37
837.30
746.31
741.30
712.07
Net Block
440.04
328.56
310.55
334.41
276.31
258.39
246.78
246.71
259.29
227.95
Gross Block
753.54
601.67
540.54
537.46
456.51
420.25
386.67
366.57
359.92
311.89
Accumulated Depreciation
313.49
273.11
229.99
203.06
180.19
161.85
139.89
119.86
100.63
83.94
Non Current Assets
779.63
586.31
370.37
356.49
331.58
278.78
271.13
260.89
269.10
257.70
Capital Work in Progress
131.23
55.17
46.36
4.81
39.00
3.75
0.08
6.69
2.29
22.27
Non Current Investment
184.83
184.83
2.75
2.99
3.00
3.94
24.27
7.49
7.52
7.49
Long Term Loans & Adv.
23.53
17.74
10.71
14.28
13.27
12.70
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
777.76
900.94
980.65
943.71
866.22
720.60
566.17
485.42
472.21
454.36
Current Investments
195.25
366.78
497.26
394.68
298.92
81.05
0.00
0.00
0.00
0.00
Inventories
187.98
150.27
134.40
104.53
101.03
111.67
83.81
80.77
74.69
83.57
Sundry Debtors
275.19
262.35
235.51
191.27
136.05
345.58
344.82
302.80
322.42
313.31
Cash & Bank
14.96
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96
20.39
Other Current Assets
104.38
0.38
0.20
0.15
110.69
55.41
59.68
58.00
60.13
37.09
Short Term Loans & Adv.
104.21
95.97
101.48
96.84
110.29
54.66
59.58
57.87
60.13
37.09
Net Current Assets
341.96
441.19
704.37
704.23
677.90
449.27
449.62
399.61
395.75
353.61
Total Assets
1,557.39
1,487.25
1,351.02
1,300.20
1,197.80
999.38
837.30
746.31
741.31
712.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
139.67
126.66
-13.98
84.20
879.69
133.92
121.97
91.11
28.31
30.38
PBT
208.82
145.55
87.44
103.57
843.44
165.34
148.07
37.06
43.69
71.15
Adjustment
1.65
38.51
20.75
-4.40
33.13
16.60
25.01
63.44
35.22
20.46
Changes in Working Capital
-17.33
-19.52
-93.71
9.47
167.35
-15.87
-22.77
1.75
-42.73
-56.21
Cash after chg. in Working capital
193.14
164.53
14.49
108.65
1,043.91
166.07
150.31
102.25
36.18
35.40
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
-28.33
-11.14
-7.87
-5.02
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-32.03
-111.89
-142.50
-116.05
-260.92
-89.46
-29.46
-14.31
-28.06
-116.60
Net Fixed Assets
-183.92
-69.64
-55.43
-41.77
-69.55
-32.72
-10.92
-13.11
-28.00
-86.16
Net Investments
84.45
-61.38
-102.46
-95.95
-214.42
-60.83
-16.87
-2.68
-9.37
-30.56
Others
67.44
19.13
15.39
21.67
23.05
4.09
-1.67
1.48
9.31
0.12
Cash from Financing Activity
-119.58
-1.39
12.04
-31.45
-526.12
4.56
-58.49
-47.91
-5.67
95.00
Net Cash Inflow / Outflow
-11.95
13.38
-144.43
-63.30
92.65
49.02
34.02
28.88
-5.42
8.79
Opening Cash & Equivalents
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96
20.39
11.60
Closing Cash & Equivalent
14.96
25.19
11.81
156.23
219.53
126.89
77.86
43.85
14.96
20.39

Financial Ratios

Consolidated /

Standalone
Description
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
128.95
117.31
123.07
119.21
113.34
80.86
66.82
55.35
53.53
49.58
ROA
10.64%
7.08%
4.64%
6.36%
61.71%
15.17%
15.00%
3.46%
6.24%
10.22%
ROE
15.50%
9.86%
5.99%
8.07%
82.49%
22.35%
23.05%
5.60%
10.43%
16.62%
ROCE
18.13%
13.49%
8.50%
10.41%
92.09%
22.63%
23.71%
8.07%
9.95%
16.18%
Fixed Asset Turnover
1.88
2.03
1.92
1.76
1.85
2.22
2.03
2.00
1.74
2.06
Receivable days
77.14
78.41
75.30
68.16
108.62
140.48
154.96
157.34
198.66
193.26
Inventory Days
48.54
44.83
42.16
42.80
47.97
39.77
39.38
39.12
49.46
50.50
Payable days
31.03
27.82
26.91
26.15
26.89
25.89
27.07
26.89
43.96
39.63
Cash Conversion Cycle
94.65
95.43
90.54
84.81
129.69
154.35
167.27
169.57
204.15
204.12
Total Debt/Equity
0.18
0.13
0.09
0.05
0.07
0.25
0.24
0.38
0.44
0.42
Interest Cover
22.81
22.33
15.74
20.61
36.10
16.75
13.80
3.44
3.42
7.33

News Update


  • JB Chemicals to buy-back up to 12.5 lakh shares
    24th May 2017, 12:36 PM

    The board of directors at its meeting held on May 23, 2017 had approved for the same

    Read More
  • JB Chem & Pharma - Quarterly Results
    23rd May 2017, 12:00 AM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.